References
- CastelinoRLBajorekBVChenTFAre interventions recommended by pharmacists during Home Medicines Review evidence-based?J Eval Clin Pract201117110411020722881
- CarterSRChenTFWhiteLHome medicines reviews: a quantitative study of the views of recipients and eligible non-recipientsInt J Pharm Pract201220420921722775517
- AbdullaAAdamsNBoneMGuidance on the management of pain in older peopleAge Ageing201342i1i5723420266
- American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsJ Am Geriatr Soc20095781331134619573219
- CroffordLRational use of analgesic and antiinflammatory drugsN Engl J Med2001345251844184611752364
- CourtneyPDohertyMKey questions concerning paracetamol and NSAIDs for osteoarthritisAnn Rheum Dis200261976777312176799
- SandlerDBurrFWeinbergCNonsteroidal anti-inflammatory drugs and the risk for chronic renal diseaseAnn Intern Med199111531651722058870
- WinkelmayerWWalkarSMogunHSolomonDNonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injuryAm J Med2008121121092109819028206
- EjazPBhojaniKJoshiVNSAIDS and kidneyJ Assoc Physicians India20045263264015847359
- MichielsenPHeinemannLMihatschMSchnüllePGrafHKochKMNon-phenacetin analgesics and analgesic nephropathyNephrol Dial Transplant20092441253125919037086
- BorneRFNonsteroidal anti-inflammatory agentsLemkeTLWilliamsDAFoye’s Principles of Medicinal Chemistry6th edPhiladelphiaLippincott Williams & Wilkins2007
- NanraRStuart-TaylorJde LeonAWhiteKAnalgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in AustraliaKidney Int19781317992362034
- StewartJAnalgesic abuse and renal failure in AustralasiaKidney Int19781317278713271
- [No authors listed]List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration, HHS. Final ruleFed Regist19996444109441094710557618
- [No authors listed]Some pharmaceutical drugsIARC Monogr Eval Carcinog Risk Chem Hum1987241337
- MichielsenPIn memoriam ‘analgesic nephropathy’ (circa 1972–2006)Nephrol Dial Transplant2007224999100117213226
- BluemleLWJrGoldbergMRenal accumulation of salicylate and phenacetin: possible mechanisms in the nephropathy of analgesic abuseJ Clin Invest19694711250725145813230
- ChangSMathewTMcDonaldSAnalgesic nephropathy and renal replacement therapy in Australia: trends, comorbidities and outcomesClin J Am Soc Nephrol20083376877618272825
- BroeMElseviersMOver-the-counter analgesic useJ Am Soc Nephrol200920102098210319423685
- PernegerTVWheltonPKKlagMJRisk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugsN Engl J Med199433125167516797969358
- DelzellEShapiroSA review of epidemiologic studies of nonnarcotic analgesics and chronic renal diseaseMedicine (Baltimore)19987721021219556702
- FeinsteinAHeinemannLCurhanGRelationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and NephropathyKidney Int20005862259226411115060
- ForedMEjerbladELindbladPAcetaminophen, aspirin, and chronic renal failureN Engl J Med2001345251801180811752356
- KelkarMClevesMFosterHHoganWJamesLMartinBAcute and chronic acetominophen use and renal disease: a case-control study using pharmacy and medical claimsJ Manag Care Pharm201218323424622468732
- Australian GovernmentThe Standard for the Uniform Scheduling of Medicines and Poisons42013 Available from http://www.comlaw.gov.au/Details/F2014L01343Accessed July 1, 2014
- MichielsenPDe SchepperPTrends of analgesic nephropathy in two high-endemic regions with different legislationJ Am Soc Nephrol200112355055611181803